Delving into the Latest Updates on Tetanus Vaccine,Adsorbed (Sinovac Life Sciences) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms-

Target-

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesOther Diseases

Active Indication

Tetanus

Inactive Indication-

Originator Organization

Beijing Kexing Zhongwei Biotech Co. Ltd.

Active Organization

Beijing Kexing Zhongwei Biotech Co. Ltd.

Inactive Organization-

Drug Highest PhaseNDA/BLA

First Approval Date-

Regulation-

Login to view timeline

Phase I: Evaluate the safety of the trial vaccine in adults aged 18 to 44, and provide safety evidence for the subsequent Phase III clinical trial Phase III: Evaluate the immunogenicity of the trial vaccine in adults aged 18 to 44, to verify that the trial vaccine is non-inferior to the positive control vaccine.

Start Date01 Sep 2023

Sponsor / Collaborator

Beijing Kexing Zhongwei Biotech Co. Ltd.

NCT06049940 / CompletedPhase 3

Randomized, Double-blind, Controlled Phase Ⅰ and Phase Ⅲ Clinical Trial to Evaluate the Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

This is a randomized, double-blind, positive controlled design clinical trial of tetanus vaccine, adsorbed manufactured by Sinovac Life Sciences Co., Ltd.The purpose of this study is to evaluate the safety and immunogenicity of tetanus vaccine, adsorbed in 18
44 years old population.

Start Date01 Sep 2023

Sponsor / Collaborator

Beijing Kexing Zhongwei Biotech Co. Ltd.

100 Clinical Results associated with Tetanus Vaccine,Adsorbed (Sinovac Life Sciences)

Login to view more data

100 Translational Medicine associated with Tetanus Vaccine,Adsorbed (Sinovac Life Sciences)

Login to view more data

100 Patents (Medical) associated with Tetanus Vaccine,Adsorbed (Sinovac Life Sciences)

Login to view more data

100 Deals associated with Tetanus Vaccine,Adsorbed (Sinovac Life Sciences)

Login to view more data